Deep sequencing reveals microRNAs predictive of antiangiogenic drug response

The majority of metastatic renal cell carcinoma (RCC) patients are treated with tyrosine kinase inhibitors (TKI) in first-line treatment; however, a fraction are refractory to these antiangiogenic drugs. MicroRNAs (miRNAs) are regulatory molecules proven to be accurate biomarkers in cancer. Here, we...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JCI Insight
Prif Awduron: García-Donas, Jesús, Beuselinck, Benoit, Inglada-Pérez, Lucía, Graña, Osvaldo, Schöffski, Patrick, Wozniak, Agnieszka, Bechter, Oliver, Apellániz-Ruiz, Maria, Leandro-García, Luis Javier, Esteban, Emilio, Castellano, Daniel E., González del Alba, Aranzazu, Climent, Miguel Angel, Hernando, Susana, Arranz, José Angel, Morente, Manuel, Pisano, David G., Robledo, Mercedes, Rodriguez-Antona, Cristina
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Clinical Investigation 2016
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5033860/
https://ncbi.nlm.nih.gov/pubmed/27699216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.86051
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg